[Analysis of national leprosy surveillance data in Mauritania from 2009 to 2019].

Analyse des données nationales de surveillance de la lèpre en Mauritanie de 2009 à 2019.

Journal

Medecine tropicale et sante internationale
ISSN: 2778-2034
Titre abrégé: Med Trop Sante Int
Pays: France
ID NLM: 9918227363206676

Informations de publication

Date de publication:
30 06 2023
Historique:
received: 27 10 2022
accepted: 27 03 2023
medline: 2 8 2023
pubmed: 1 8 2023
entrez: 1 8 2023
Statut: epublish

Résumé

Leprosy is a chronic infectious disease that mainly affects the skin, mucous membranes and the peripheral nervous system. Its elimination as a public health problem seems to lead to its ignorance and therefore to a risk of late diagnosis. An analysis of leprosy surveillance data in Mauritania was conducted to determine epidemiological trends and clinical forms of reported cases. The retrospective study was based on the epidemiological records of leprosy in Mauritania from 2009 to 2019. The diagnosis of leprosy was made on the basis of the diagnostic criteria of the World Health Organization (WHO). Data were analyzed using Epi Info version 7.2.5.0. The frequencies, proportions, and rates were calculated. Over the past 11 years, 164 cases have been notified. Among the notified cases, 96/164 (58.5%) were males and 68/164 (41.5%) females, with a sex ratio of 1.4. The mean age (± standard deviation) was 44.0 ± 17.1 years [range, 9 - 86 years], and the median was 45 years [interquartile range, 32.5; 57.5]. Children under the age of 16 accounted for 9/164 (5.5%). The wilayas (i.e. "regions") of Nouakchott were the most endemic regions in the country. The multibacillary form (MB) represented 109/164 (66.5%) cases among the observed clinical forms. The average annual incidence was 0.3 case/100,000 population for MB and 0.1 case/100,000 for PB (paucibacillary). All reported cases were treated with multidrug therapy. The results of leprosy surveillance showed a persistence of this disease in Mauritania. It is necessary to relaunch leprosy services at all levels in order to continue to reduce the morbidity associated with this disease, and eventually eliminate it from the country.

Identifiants

pubmed: 37525686
doi: 10.48327/mtsi.v3i2.2023.361
pmc: PMC10387306
pii:
doi:

Substances chimiques

Leprostatic Agents 0

Types de publication

English Abstract Journal Article

Langues

fre

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023 SFMTSI.

Références

J Am Acad Dermatol. 2020 Jul;83(1):1-14
pubmed: 32229279
J Eur Acad Dermatol Venereol. 2019 Jul;33(7):1205-1213
pubmed: 30945360
Bull Soc Pathol Exot. 2018;111(2):99-103
pubmed: 30789236
Med Trop (Mars). 2008 Feb;68(1):33-7
pubmed: 18478769
Med Mal Infect. 2005 Apr;35(4):225-7
pubmed: 15914293
Ann Dermatol Venereol. 2001 Mar;128(3 Pt 1):217-9
pubmed: 11319383
BMC Public Health. 2020 Aug 18;20(1):1254
pubmed: 32811449
Glob Health Action. 2016 Nov 23;9:32962
pubmed: 27885973

Auteurs

Boushab Mohamed Boushab (BM)

Médecine interne et maladies infectieuses, Centre hospitalier de Kiffa, Assaba, Mauritanie.
Programme national de lutte contre la tuberculose et la lèpre (PNTL), Nouakchott, Mauritanie.
Épidémiologie de terrain et de laboratoire du Burkina Faso, Université Joseph Ki-Zerbo, Ouagadougou, Burkina Faso.

Pauline Kiswendsida Yanogo (PK)

Faculté de médecine, Université Joseph Ki-Zerbo, Ouagadougou, Burkina Faso.
Épidémiologie de terrain et de laboratoire du Burkina Faso, Université Joseph Ki-Zerbo, Ouagadougou, Burkina Faso.

Djibril Barry (D)

Épidémiologie de terrain et de laboratoire du Burkina Faso, Université Joseph Ki-Zerbo, Ouagadougou, Burkina Faso.

Mohamedou Hmeind Maham (MH)

Épidémiologie de terrain et de laboratoire du Burkina Faso, Université Joseph Ki-Zerbo, Ouagadougou, Burkina Faso.
Direction générale des Services de santé des Forces armées et de sécurité, Nouakchott, Mauritanie.

Abdallahi Mohamed Kheirou Traoré (AMK)

Programme national de lutte contre la tuberculose et la lèpre (PNTL), Nouakchott, Mauritanie.

Elhadj Malick Kane (EM)

Programme national de lutte contre la tuberculose et la lèpre (PNTL), Nouakchott, Mauritanie.

Leonardo Basco (L)

Aix-Marseille Université, IRD, AP-HM, SSA, VITROME, Marseille, France.
IHU-Méditerranée Infection, Marseille, France.

Nicolas Meda (N)

Faculté de médecine, Université Joseph Ki-Zerbo, Ouagadougou, Burkina Faso.
Épidémiologie de terrain et de laboratoire du Burkina Faso, Université Joseph Ki-Zerbo, Ouagadougou, Burkina Faso.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH